AcquisitionOther
YUMANITY THERAPEUTICS, INC. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
YUMANITY THERAPEUTICS, INC. -> target · $1.34
The exact amount of the special dividend will be calculated after Yumanitys outstanding obligations and net cash position as of the actual closing date of the merger are determined.
Open source record (SEC) ↗